Literature DB >> 32516748

Latency of preterm hypertensive disorders of pregnancy and subsequent cardiovascular complications.

Joshua I Rosenbloom1, Dustin Stwalley2, Kathryn J Lindley3, D Michael Nelson4, Margaret A Olsen2, Molly J Stout4.   

Abstract

OBJECTIVES: To test the hypothesis that increasing latency from diagnosis to delivery in patients with preterm hypertensive disorders of pregnancy is associated with an increased maternal risk of cardiovascular admission after delivery. STUDY
DESIGN: Retrospective cohort from the IBM MarketScan® Commercial Database from 2006 to 2016. Patients age 15-45 years with a preterm delivery complicated by a hypertensive disorder of pregnancy, at least 6 months of continuous insurance coverage prior to delivery and at least 365 days of coverage post-delivery were included. MAIN OUTCOME MEASURES: Hospital readmission after delivery for a composite of acute cardiovascular events (cardiomyopathy, heart failure, cardiac arrest, myocardial infarction) or cerebrovascular events. Cox proportional hazards were used to estimate the risk of the primary outcome for each week of latency from diagnosis to delivery.
RESULTS: There were 34,989 women in the study with a median follow-up of 2.57 years (IQR 1.66 to 1.54 years) with a median time from diagnosis to delivery of three days (IQR 0 to 14 days). An increasing time from diagnosis to delivery was associated with an increased risk of an acute cardiovascular event (adjusted HR 1.06, 95% CI 1.01, 1.11 per week), in models adjusted for maternal comorbidities and demographic factors. Later gestational age at diagnosis was associated with a decreased risk of maternal cardiovascular admission after delivery (aHR 0.94, 95% CI 0.91, 0.98 for each week increase in gestational age).
CONCLUSIONS: Prolonging expectant management of preterm hypertensive disorders of pregnancy is associated with an increased risk of maternal cardiovascular disease after delivery.
Copyright © 2020 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiovascular disease; Expectant management; Hypertensive disorders of pregnancy; Preterm

Mesh:

Substances:

Year:  2020        PMID: 32516748      PMCID: PMC7548294          DOI: 10.1016/j.preghy.2020.05.015

Source DB:  PubMed          Journal:  Pregnancy Hypertens        ISSN: 2210-7789            Impact factor:   2.899


  21 in total

1.  ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia.

Authors: 
Journal:  Obstet Gynecol       Date:  2019-01       Impact factor: 7.661

2.  A note on quantifying follow-up in studies of failure time.

Authors:  M Schemper; T L Smith
Journal:  Control Clin Trials       Date:  1996-08

3.  Cardiovascular disease risk factors after early-onset preeclampsia, late-onset preeclampsia, and pregnancy-induced hypertension.

Authors:  Jan H W Veerbeek; Wietske Hermes; Anath Y Breimer; Bas B van Rijn; Steven V Koenen; Ben W Mol; Arie Franx; Christianne J M de Groot; Maria P H Koster
Journal:  Hypertension       Date:  2015-01-05       Impact factor: 10.190

4.  Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial.

Authors:  Kim Broekhuijsen; Gert-Jan van Baaren; Maria G van Pampus; Wessel Ganzevoort; J Marko Sikkema; Mallory D Woiski; Martijn A Oudijk; Kitty W M Bloemenkamp; Hubertina C J Scheepers; Henk A Bremer; Robbert J P Rijnders; Aren J van Loon; Denise A M Perquin; Jan M J Sporken; Dimitri N M Papatsonis; Marloes E van Huizen; Corla B Vredevoogd; Jozien T J Brons; Mesrure Kaplan; Anton H van Kaam; Henk Groen; Martina M Porath; Paul P van den Berg; Ben W J Mol; Maureen T M Franssen; Josje Langenveld
Journal:  Lancet       Date:  2015-03-25       Impact factor: 79.321

Review 5.  Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  Cheryl Bushnell; Louise D McCullough; Issam A Awad; Monique V Chireau; Wende N Fedder; Karen L Furie; Virginia J Howard; Judith H Lichtman; Lynda D Lisabeth; Ileana L Piña; Mathew J Reeves; Kathryn M Rexrode; Gustavo Saposnik; Vineeta Singh; Amytis Towfighi; Viola Vaccarino; Matthew R Walters
Journal:  Stroke       Date:  2014-02-06       Impact factor: 7.914

6.  All-Cause and Cause-Specific Mortality After Hypertensive Disease of Pregnancy.

Authors:  Lauren H Theilen; Alison Fraser; Michael S Hollingshaus; Karen C Schliep; Michael W Varner; Ken R Smith; M Sean Esplin
Journal:  Obstet Gynecol       Date:  2016-08       Impact factor: 7.661

Review 7.  Promoting Risk Identification and Reduction of Cardiovascular Disease in Women Through Collaboration With Obstetricians and Gynecologists: A Presidential Advisory From the American Heart Association and the American College of Obstetricians and Gynecologists.

Authors:  Haywood L Brown; John J Warner; Eugenia Gianos; Martha Gulati; Alexandria J Hill; Lisa M Hollier; Stacey E Rosen; Mary L Rosser; Nanette K Wenger
Journal:  Circulation       Date:  2018-05-10       Impact factor: 29.690

8.  Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial.

Authors:  B M Sibai; B M Mercer; E Schiff; S A Friedman
Journal:  Am J Obstet Gynecol       Date:  1994-09       Impact factor: 8.661

9.  Effect of early-onset preeclampsia on cardiovascular risk in the fifth decade of life.

Authors:  Anouk Bokslag; Pim W Teunissen; Constantijn Franssen; Floortje van Kesteren; Otto Kamp; Wessel Ganzevoort; Walter J Paulus; Christianne J M de Groot
Journal:  Am J Obstet Gynecol       Date:  2017-02-14       Impact factor: 8.661

Review 10.  Epidemiology of hypertensive disorders in pregnancy: prevalence, risk factors, predictors and prognosis.

Authors:  Mitsumasa Umesawa; Gen Kobashi
Journal:  Hypertens Res       Date:  2016-09-29       Impact factor: 3.872

View more
  5 in total

1.  Preeclampsia Predicts Risk of Hospitalization for Heart Failure With Preserved Ejection Fraction.

Authors:  Dominique Williams; Molly J Stout; Joshua I Rosenbloom; Margaret A Olsen; Karen E Joynt Maddox; Elena Deych; Victor G Davila-Roman; Kathryn J Lindley
Journal:  J Am Coll Cardiol       Date:  2021-12-07       Impact factor: 24.094

Review 2.  Interventions to Mitigate Risk of Cardiovascular Disease After Adverse Pregnancy Outcomes: A Review.

Authors:  Amanda R Jowell; Amy A Sarma; Martha Gulati; Erin D Michos; Arthur J Vaught; Pradeep Natarajan; Camille E Powe; Michael C Honigberg
Journal:  JAMA Cardiol       Date:  2022-03-01       Impact factor: 14.676

Review 3.  Hypertensive Disorders of Pregnancy and Heart Failure Risk.

Authors:  Sarah A Goldstein; Neha J Pagidipati
Journal:  Curr Hypertens Rep       Date:  2022-03-28       Impact factor: 4.592

4.  Prevalence of a History of Metabolic or Hypertensive Pregnancy Disorder in Patients With Myocardial Infarction and Non-obstructive Coronary Arteries: An Observational Cohort Study.

Authors:  Tobias F S Pustjens; Nousjka P A Vranken; Gwyneth Jansen; Patty J C Winkler; Mera Stein; Loes Hoebers; Bas Kietselaer; Marc E A Spaanderman; Saman Rasoul; Chahinda Ghossein-Doha; Arnoud W J van 't Hof
Journal:  Front Cardiovasc Med       Date:  2022-07-15

Review 5.  Peripartum considerations for women with cardiac disease.

Authors:  Hanna Hussey; Patrick Hussey; Marie-Louise Meng
Journal:  Curr Opin Anaesthesiol       Date:  2021-06-01       Impact factor: 2.733

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.